China Biopharma Podcast: Interview with AZ, Sciwind’s Ecnoglutide Results and China Law Firm On BIOSECURE
Dexter Yan talks about his September interview with Sharon Barr, AstraZeneca’s executive vice president, Biopharmaceuticals R&D. Hu Xu shares her articles on Sciwind’s ecnoglutide Phase III results and a Chinese law firm’s view on the proposed US BIOSECURE Act.